
Genus plc
GENSFOTCHealthcare● Active
$35.00
+$3.94(+12.67%)
Market Cap$2.3B
P/E Ratio—
52W High$37.25
52W Low$26.01
Genus plc(GENSF)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · GENSF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.67B | $0.67B | $0.69B | $0.59B | $0.57B |
| Cost of Revenue | $0.00B | $0.49B | $0.45B | $0.37B | $0.34B |
| Gross Profit | $0.67B | $0.18B | $0.24B | $0.23B | $0.23B |
| Gross Margin %(computed) | 100.00% | 26.72% | 34.70% | 38.09% | 40.43% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.03B | $0.09B | $0.07B | $0.07B |
| G&A Expenses | $0.00B | $0.11B | $0.09B | $0.09B | $0.10B |
| Total Operating Expenses | $0.63B | $0.17B | ($0.65B) | $0.17B | $0.17B |
| Operating Income | $0.04B | $0.01B | $0.04B | $0.06B | $0.06B |
| Operating Margin %(computed) | 6.30% | 0.96% | 5.87% | 9.54% | 10.71% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | $0.03B | $0.01B | $0.04B | $0.05B | $0.06B |
| Income Tax Expense | $0.00B | $0.00B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.02B | $0.01B | $0.03B | $0.04B | $0.05B |
| Net Margin %(computed) | 2.87% | 1.18% | 4.83% | 6.89% | 8.24% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.25 | $0.12 | $0.51 | $0.63 | $0.73 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| EBITDA | $0.09B | $0.07B | $0.09B | $0.08B | $0.08B |
| EBITDA Margin %(computed) | 13.93% | 11.02% | 12.69% | 13.45% | 14.33% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · GBP · B
深入了解Genus plc
关于Genus plc(GENSF)损益表
Genus plc(GENSF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GENSF实现营收$0.67B,毛利润$0.67B(毛利率100.00%),净利润$0.02B(净利率2.87%)。
常见问题
GENSF · 4 问Genus plc(GENSF)2025财年营收为$0.67B,同比up0.6%。
GENSF revenueGENSF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09